Literature DB >> 5879792

Urinary excretion of methylamphetamine in man.

A H Beckett, M Rowland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5879792     DOI： 10.1038/2061260a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

1.  Interaction and Transport of Methamphetamine and its Primary Metabolites by Organic Cation and Multidrug and Toxin Extrusion Transporters.

Authors:  David J Wagner; Jennifer E Sager; Haichuan Duan; Nina Isoherranen; Joanne Wang
Journal:  Drug Metab Dispos       Date:  2017-04-20       Impact factor: 3.922

2.  Deprenyl is metabolized to methamphetamine and amphetamine in man.

Authors:  G P Reynolds; J D Elsworth; K Blau; M Sandler; A J Lees; G M Stern
Journal:  Br J Clin Pharmacol       Date:  1978-12       Impact factor: 4.335

3.  Stereoselectivity in the human metabolism of methamphetamine.

Authors:  Linghui Li; Tom Everhart; Peyton Jacob Iii; Reese Jones; John Mendelson
Journal:  Br J Clin Pharmacol       Date:  2010-02       Impact factor: 4.335

4.  Effects of ethanol ingestion and urinary acidity on the metabolism of triethylamine in man.

Authors:  B Akesson; S Skerfving
Journal:  Int Arch Occup Environ Health       Date:  1990       Impact factor: 3.015

5.  Mechanistic PBPK Modeling of Urine pH Effect on Renal and Systemic Disposition of Methamphetamine and Amphetamine.

Authors:  Weize Huang; Lindsay C Czuba; Nina Isoherranen
Journal:  J Pharmacol Exp Ther       Date:  2020-03-20       Impact factor: 4.030

Review 6.  Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices.

Authors:  Rafael de la Torre; Magí Farré; Mónica Navarro; Roberta Pacifici; Piergiorgio Zuccaro; Simona Pichini
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

7.  The effect of variations in urinary pH on the pharmacokinetics of diethylcarbamazine.

Authors:  G Edwards; A M Breckenridge; K K Adjepon-Yamoah; M L Orme; S A Ward
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

8.  Inhibition of methamphetamine sensitization by post-methamphetamine treatment with SCH 23390 or haloperidol.

Authors:  H Kuribara
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

9.  Contrasting effects on methamphetamine sensitization of ceruletide, a cholecystokinin-like decapeptide, and haloperidol.

Authors:  H Kuribara
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

Review 10.  Drug structure-transport relationships.

Authors:  Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-11-24       Impact factor: 2.745
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.